secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001493152-23-018380
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic adopts new bylaws with advance notice provisions for shareholder proposals.
--------------------------------------------------------------------------------

- Board adopted new amended and restated bylaws on May 18, 2023.
- New bylaws add advance notice requirements for shareholder proposals at meetings or consent solicitations.
- Replaces prior bylaws; full text filed as Exhibit 3.2.
- No financial or operational changes reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/0001493152-23-018380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer